Balyasny Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-652,644
| Closed | -$3.45M | – | 2408 |
|
|
2025
Q1 | $3.45M | Buy |
+652,644
| New | +$3.45M | 0.01% | 974 |
|
|
2024
Q3 | – | Sell |
-245,210
| Closed | -$1.84M | – | 2309 |
|
|
2024
Q2 | $1.84M | Buy |
+245,210
| New | +$1.84M | ﹤0.01% | 1078 |
|
|
2023
Q3 | – | Sell |
-800,320
| Closed | -$5.98M | – | 2146 |
|
|
2023
Q2 | $5.98M | Buy |
800,320
+733,334
| +1,095% | +$5.48M | 0.01% | 727 |
|
|
2023
Q1 | $447K | Sell |
66,986
-84,353
| -56% | -$563K | ﹤0.01% | 1562 |
|
|
2022
Q4 | $1.17M | Buy |
+151,339
| New | +$1.17M | ﹤0.01% | 1214 |
|